Your browser is no longer supported. Please, upgrade your browser.
PTLA Portola Pharmaceuticals, Inc. daily Stock Chart
PTLA [NASD]
Portola Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.06 Insider Own0.60% Shs Outstand86.31M Perf Week-6.11%
Market Cap556.70M Forward P/E- EPS next Y-2.25 Insider Trans-0.96% Shs Float76.88M Perf Month-35.82%
Income-290.70M PEG- EPS next Q-0.78 Inst Own- Short Float23.72% Perf Quarter-73.10%
Sales116.60M P/S4.77 EPS this Y23.40% Inst Trans3.41% Short Ratio9.24 Perf Half Y-75.76%
Book/sh1.67 P/B3.86 EPS next Y25.70% ROA-60.50% Target Price20.33 Perf Year-82.76%
Cash/sh4.97 P/C1.30 EPS next 5Y- ROE-296.80% 52W Range5.31 - 37.95 Perf YTD-72.99%
Dividend- P/FCF- EPS past 5Y-4.90% ROI- 52W High-83.00% Beta2.01
Dividend %- Quick Ratio4.50 Sales past 5Y64.70% Gross Margin77.20% 52W Low21.47% ATR0.89
Employees408 Current Ratio4.50 Sales Q/Q90.80% Oper. Margin- RSI (14)36.16 Volatility11.05% 13.54%
OptionableYes Debt/Eq2.64 EPS Q/Q6.80% Profit Margin- Rel Volume0.83 Prev Close7.13
ShortableYes LT Debt/Eq2.50 EarningsFeb 26 AMC Payout- Avg Volume1.97M Price6.45
Recom2.30 SMA20-11.20% SMA50-38.91% SMA200-71.73% Volume1,634,200 Change-9.54%
Jan-10-20Downgrade Oppenheimer Outperform → Perform
Nov-08-19Initiated Goldman Neutral $35
Aug-05-19Resumed Credit Suisse Neutral $35
Jul-10-19Resumed Credit Suisse Neutral
Aug-27-18Upgrade Credit Suisse Underperform → Neutral
Aug-10-18Downgrade Credit Suisse Neutral → Underperform
Mar-01-18Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-01-17Initiated Goldman Buy $75
Aug-24-17Upgrade Credit Suisse Neutral → Outperform
Jun-26-17Reiterated Morgan Stanley Overweight $50 → $70
Jun-26-17Reiterated Citigroup Buy $51 → $78
Feb-24-17Upgrade Oppenheimer Perform → Outperform
Jan-03-17Upgrade Citigroup Neutral → Buy
Dec-27-16Reiterated Credit Suisse Outperform $20 → $29
Aug-19-16Downgrade Citigroup Buy → Neutral
May-31-16Downgrade Credit Suisse Outperform → Neutral $33 → $30
Mar-28-16Reiterated Credit Suisse Outperform $47 → $34
Mar-28-16Downgrade Goldman Buy → Neutral $65 → $30
Dec-18-15Initiated Goldman Buy
Apr-01-20 04:02PM  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire -9.12%
Mar-18-20 04:11PM  Portola Pharmaceuticals Announces Proactive Steps Supporting Public Health Efforts to Combat Coronavirus (COVID-19) PR Newswire +14.53%
Mar-17-20 07:21PM  Edited Transcript of PTLA earnings conference call or presentation 26-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Mar-16-20 10:45AM  CLASS ACTION UPDATE for PTLA, GERN and CAN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE -21.49%
10:00AM  PTLA DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 ACCESSWIRE
08:05AM  Portola Pharmaceuticals Announces Results Demonstrating Andexxa® was Associated with Lowest Rate of Mortality in Patients with Multiple Types of Factor Xa Inhibitor-Related Bleeds PR Newswire
Mar-15-20 10:50PM  PORTOLA 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Portola Pharmaceuticals, Inc. - PTLA PR Newswire
05:30PM  SHAREHOLDER ALERT: PTLA BYND WBK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Mar-14-20 12:00PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm PR Newswire
Mar-13-20 10:50PM  PORTOLA 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Portola Pharmaceuticals, Inc. - PTLA Business Wire +7.71%
04:45PM  PTLA Final Deadline Monday: Rosen, a Globally Recognized Firm, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action PTLA Business Wire
01:45PM  SHAREHOLDER ALERT: PTLA WBK HPQ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:59AM  PTLA FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 ACCESSWIRE
Mar-12-20 11:00AM  PTLA INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 GlobeNewswire -18.03%
10:50AM  ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action PTLA GlobeNewswire
10:45AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, QD and AAN ACCESSWIRE
Mar-11-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ALGN, OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire -7.17%
05:30PM  SHAREHOLDER ALERT: PTLA LK JELD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
04:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA ACCESSWIRE
03:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, WBK and WWE ACCESSWIRE
03:07PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Business Wire
10:50AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, WWE and TLRY ACCESSWIRE
09:58AM  PTLA UPCOMING DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 ACCESSWIRE
Mar-10-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ALGN, PTLA, QD and WWE GlobeNewswire +8.49%
02:40PM  CLASS ACTION UPDATE for PTLA, WWE and JELD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:10PM  ROSEN, INVESTOR COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16 Deadline in Securities Class Action - PTLA ACCESSWIRE
10:50AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, WWE and CAN ACCESSWIRE
Mar-09-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTLA, QD, TUP, TVTY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire -9.30%
06:04PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA GlobeNewswire
03:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SSL, PTLA and BYND ACCESSWIRE
03:00PM  PTLA DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 Business Wire
02:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, LK and ALGN ACCESSWIRE
10:55AM  Portola Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
10:45AM  CLASS ACTION UPDATE for SSL, PTLA and WBK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:57AM  PTLA DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 ACCESSWIRE
09:37AM  PTLA ALERT: Pawar Law Group Reminds Investors of March 16 Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. PTLA GlobeNewswire
Mar-08-20 05:15PM  SHAREHOLDER ALERT: PTLA QD WBK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:00PM  ROSEN, NATIONAL TRIAL COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action PTLA GlobeNewswire
10:40AM  CLASS ACTION UPDATE for PTLA, ALGN and CAN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Mar-06-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire -6.97%
11:50AM  SHAREHOLDER ALERT: OPRA PTLA MGPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
11:06AM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
Mar-05-20 05:10PM  SHAREHOLDER ALERT: PTLA WBK ALGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
05:00PM  Portola Pharmaceuticals, Inc. Shareholder Investigation: Class Action Lawsuit Filed ACCESSWIRE
03:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA ACCESSWIRE
10:00AM  WBAI & PTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines GlobeNewswire
08:30AM  New Data Demonstrates Andexxa® Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors PR Newswire
Mar-04-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTLA, QD, TUP, TVTY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire +5.44%
01:40PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, GERN and BYND ACCESSWIRE
12:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm GlobeNewswire
10:45AM  SHAREHOLDER ALERT: PTLA GERN AAN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:02AM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Portola Pharmaceuticals, Inc. to Contact the Firm Newsfile
Mar-03-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of PTLA and QD GlobeNewswire
05:20PM  CLASS ACTION UPDATE for PTLA, HPQ and MGPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:59PM  Shareholder Alert: Robbins LLP Announces Another Complaint Filed Against Portola Pharmaceuticals, Inc. (PTLA) Business Wire
03:30PM  PTLA Investor Alert: Lawsuit Filed on Behalf of Portola Pharmaceuticals Shareholders ACCESSWIRE
03:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA GlobeNewswire
12:30PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, BDX and AAN ACCESSWIRE
12:00PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Portola Pharmaceuticals, Inc. (PTLA) Investors Business Wire
10:48AM  WBAI & PTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines ACCESSWIRE
Mar-02-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
08:05PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Portola Pharmaceuticals, Inc. (PTLA) Investors Business Wire
04:57PM  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
12:30PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FSCT, PTLA and CCI ACCESSWIRE
11:27AM  Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. Business Wire
10:45AM  CLASS ACTION UPDATE for PTLA, TVTY and BDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
08:46AM  PTLA INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors in Portola Pharmaceuticals, Inc. of a Filing Deadline in a Securities Class Action Lawsuit against the Company ACCESSWIRE
Mar-01-20 10:30AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, HPQ and JELD ACCESSWIRE
Feb-28-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTLA, QD, TUP, TVTY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
07:43PM  PTLA INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors in Portola Pharmaceuticals, Inc. of a Filing Deadline in a Securities Class Action Lawsuit against the Company ACCESSWIRE
10:49AM  Portola Pharmaceuticals, Inc. Just Reported, And Analysts Assigned A US$20.83 Price Target Simply Wall St.
09:45AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FSCT, PTLA and WBK ACCESSWIRE
Feb-27-20 07:52PM  PTLA INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors in Portola Pharmaceuticals, Inc. of a Filing Deadline in a Securities Class Action Lawsuit against the Company Business Wire -18.77%
06:20PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, GERN and LK ACCESSWIRE
05:00PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. (PTLA) ACCESSWIRE
03:00PM  PTLA LOSS ALERT: ROSEN, A GLOBAL LAW FIRM, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action PTLA GlobeNewswire
02:15PM  SHAREHOLDER ALERT: PTLA WBK TUP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA ACCESSWIRE
10:45AM  CLASS ACTION UPDATE for PTLA, BYND and TUP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:08AM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
Feb-26-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS FSCT, OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
08:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA ACCESSWIRE
06:00PM  SHAREHOLDER ALERT: FSCT PTLA TUP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
04:01PM  Portola Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update PR Newswire
01:50PM  The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. (PLTA) ACCESSWIRE
01:20PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, QD and GERN ACCESSWIRE
12:57PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm GlobeNewswire
11:45AM  CLASS ACTION UPDATE for OPRA, PTLA and WBK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:00AM  INVESTOR ALERT - Portola Pharmaceuticals Inc. (PTLA) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 GlobeNewswire
Feb-25-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of FSCT, PTLA and QD GlobeNewswire
05:00PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. ACCESSWIRE
01:45PM  SHAREHOLDER ALERT: PTLA QD GERN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:00PM  PTLA INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 ACCESSWIRE
12:15PM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
10:45AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, GERN and LK ACCESSWIRE
Feb-24-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, PTLA, QD, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
04:38PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA GlobeNewswire
10:50AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FSCT, PTLA and LK ACCESSWIRE
09:13AM  PORTOLA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
08:00AM  Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences PR Newswire
Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation in the United States. The company offers Andexxa, an antidote for patients treated with rivaroxaban and apixaban when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding; and Bevyxxa (betrixaban), an oral, once-daily Factor Xa inhibitor for the prevention of venous thromboembolism in adult patients hospitalized for an acute medical illness. It is also advancing cerdulatinib, a dual spleen tyrosine kinase and janus kinases inhibitor in development for the treatment of hematologic cancers. In addition, the company is developing PRT2761, a Syk inhibitor that has completed Phase II clinical trial for the treatment for allergic conjunctivitis. Portola Pharmaceuticals, Inc. has collaboration agreements with Bristol-Myers Squibb; Pfizer Inc.; Bayer Pharma, AG; Janssen Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Millennium Pharmaceuticals, Inc.; SRX Cardio; LLC; Ora; and Astellas Pharma Inc. The company was founded in 2003 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RENTON HOLLINGSDirectorNov 01Option Exercise9.005,00045,00018,194Nov 04 07:32 PM
RENTON HOLLINGSDirectorNov 01Sale30.005,000150,00013,194Nov 04 07:32 PM
RENTON HOLLINGSDirectorAug 08Option Exercise9.005,00045,00018,194Aug 09 06:51 PM
RENTON HOLLINGSDirectorAug 08Sale30.005,000150,00013,194Aug 09 06:51 PM
RENTON HOLLINGSDirectorApr 15Option Exercise9.005,00045,00014,000Apr 16 07:44 PM
RENTON HOLLINGSDirectorApr 15Sale34.455,000172,2509,000Apr 16 07:44 PM